ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Adamas Completes Acquisition of OSMOLEX ER americanpharmaceuticalreview
January 14, 2021Adamas Pharmaceuticals announced the closing of the settlement of patent litigation with Osmotica Pharmaceutical, a subsidiary of Osmotica Pharmaceuticals and completes the acquisition of the global rights to OSMOLEX ER?.
Pharma Sources Insight January 2025
